Medicine · Health Sciences
7h-index350citations24works0.02yr avg
Accepting Students?
No reports yet. Know if this professor is taking students?
Research Topics
Pain Mechanisms and Treatments(6), Receptor Mechanisms and Signaling(5), Pain Management and Opioid Use(3), Pharmacological Effects and Toxicity Studies(3), Neurotransmitter Receptor Influence on Behavior(2)
Publications24 total
DEVELOPMENT OF XEN2174: NON-CLINICAL STUDIES AND AN OPEN-LABEL I/IIa STUDY OF INTRATHECAL USE IN ONCOLOGY PATIENTS WITH MODERATE TO SEVERE PAIN
Queensland's institutional digital repository (The University of Queensland)·2009
Development of novel X-conopeptide inhibitors of the norepinephrine transporter with analgesic potential
Queensland's institutional digital repository (The University of Queensland)·2008
Investigation of the anti-allodynic and anti-hyperalgesics effects of ACV1 in a rat model of neuropathic pain
Queensland's institutional digital repository (The University of Queensland)·2005
Intrathecal XEN2174 produces significant anti-allodynia in morphine-tolerant rats using the CCI-model of persistent neuropathic pain
Queensland's institutional digital repository (The University of Queensland)·2005
The pro-allodynic effects of morphine-3-glucuronide (M3G) appear to be opioid-receptor mediated
Queensland's institutional digital repository (The University of Queensland)·2004
Anti-allodynic effects of Xen2174 in rats with neuropathy. Abstract
Queensland's institutional digital repository (The University of Queensland)·2004
The pro-allodynic effects of morphine-3-glucuronide (M3G) in the rat
2004
Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study
Antiviral Therapy·2003· 15 cited
Analysis from more than 1600 newly diagnosed patients with HIV from 17 European countries shows that 10% of the patients carry primary drug-resistance: the CATCH study
2003· 14 cited
Frequency of primary reistance in subtype B is significantly lower in Europe compared to the US; analysis of 1400 patients from 16 countries: the CATCH-Study
Antiviral Therapy·2003
Absence of antinociceptive cross-tolerance between supraspinal oxycodone and intravenous morphine in the dark agouti rat
Queensland's institutional digital repository (The University of Queensland)·2000
Incomplete and assymetric antinociceptive cross-tolerance between oxycodone and morphine in the rat
Queensland's institutional digital repository (The University of Queensland)·2000
Respiratory Medicine·1999· 57 citedOpen Access
Incomplete antinociceptive cross-tolerance between oxycodone and morphine in the rat
1999
Acta Pharmacologica et Toxicologica·1981· 32 cited
Cellular and Molecular Life Sciences·1980· 80 cited
Chemischer Informationsdienst·1978
Journal of Medicinal Chemistry·1978· 124 cited
Acta Pharmacologica et Toxicologica·1976· 6 cited
page 1 of 2Next →
Frequent Co-authors
Maree T. Smith(10), E. Arrigoni‐Martelli(5), H.‐H. Frey(5), Richard J. Lewis(4), Hans Petersen(3), David van de Vijver(3), Claudia Balotta(3), Carmen de Mendoza(3), Scott DeRoo(3), Inge Derdelinckx(3), O Hamouda(3), A Hatzakis(3), A. I. M. Hoepelman(3), Andrzéj Horban(3), Klaus Korn(3), C Kuecherer(3), Ormaasen(3), Dimitrios Paraskevis(3), Elisabeth Puchhammer(3), Mika Salminen(3)